Last reviewed · How we verify
NCT05754905
High-resolution CE-MRA of Children's Hip Joint
trial testing Magnetic resonance examination in Hip in 48 participants. Completed in 31 January 2023.
30 December 2022
Quick facts
| Lead sponsor | Children's Hospital of Chongqing Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 48 |
| Start date | 1 January 2021 |
| Primary completion | 30 December 2022 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Magnetic resonance examination
Conditions studied
- Hip — all drugs for Hip →
- Vessels; Anomaly — all drugs for Vessels; Anomaly →
- Magnetic Resonance — all drugs for Magnetic Resonance →
- Three-dimensional Water-selective Cartilage (3D-WATSc) — all drugs for Three-dimensional Water-selective Cartilage (3D-WATSc) →
Sponsor
Children's Hospital of Chongqing Medical University
Who can join
Adults 6 Months to 14, any sex, with Hip or Vessels; Anomaly. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about the feasibility of enhanced three-dimensional water-selective cartilage (3D-WATSc) sequence in displaying the vessels of children's hip by magnetic resonance. The main questions it aims to answer are: * Could the images of enhanced 3D-WATSc sequence show the healthy side hip joint vessels in children? * Could the images of enhanced 3D-WATSc sequence show the vascular disease of the suffering side hip joint in children? Participants with unilateral hip disease will undergo the magnetic resonance examination including enhanced 3D-WATSc sequence. The pelvic plain film and magnetic resonance images will be collected and analysed. Researchers will compare the images of of the normal side with the images of the abnormal side to see if the enhanced 3D-WATSc sequence images could show the vascular disease of the suffering side hip joint in children?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05754905
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetic resonance examination
Trials testing the same drug.
- NCT02713568 — Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study) · NA · completed
Other recruiting trials for Hip
Currently open trials in the same condition.
- NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
- NCT05613439 — The Fast-track Centre for Hip and Knee Replacement Database · recruiting
Other Children's Hospital of Chongqing Medical University trials
Trials by the same sponsor.
- NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
- NCT07472829 — Research on Speech Development Trajectories and Predictive Models in Children With Autism Spectrum Disorder · not yet recruiting
- NCT05911893 — the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children · NA · recruiting
- NCT06404294 — The External Diaphragm Pacemaker Assisted Extubation in Premature Infants With Invasive Mechanical Ventilation · NA · recruiting
- NCT05768399 — The Role of Biomarkers in the Occurrence and Development of Asthma · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05754905 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Chongqing Medical University
- Last refreshed: 6 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05754905.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing